Martin Bachmann to Vaccines, Virus-Like Particle
This is a "connection" page, showing publications Martin Bachmann has written about Vaccines, Virus-Like Particle.
Connection Strength
3.646
-
Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2. Front Immunol. 2019; 10:1679.
Score: 0.623
-
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol. 2019; 10:1015.
Score: 0.613
-
RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion. Front Immunol. 2019; 10:736.
Score: 0.609
-
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference. Expert Rev Vaccines. 2019 01; 18(1):1-3.
Score: 0.596
-
Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin Immunol. 2017 12; 34:123-132.
Score: 0.546
-
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination. J Control Release. 2017 04 10; 251:92-100.
Score: 0.526
-
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines. Sci Rep. 2017 06 19; 7(1):3811.
Score: 0.134